Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Are the Projected Market Size and Growth Rates for the Budesonide Market From 2025 To 2029?

In the past few years, there has been a significant growth in the budesonide market size. It is projected to rise from $9.72 billion in 2024 to $10.36 billion in 2025, with a compound annual growth rate (CAGR) of 6.6%. This considerable growth during the historical period is due to factors such as an increase in respiratory illnesses, heightened awareness about inhaled corticosteroids, the unveiling of combination therapies based on budesonide, the proliferation of healthcare facilities and accessibility, as well as the off-label usage of budesonide for inflammatory bowel diseases.

The market size of budesonide is anticipated to experience significant growth in the coming years, ballooning to $13.25 billion in 2029 with a compound annual growth rate (CAGR) of 6.3%. The factors contributing to this predicted growth for the forecast period include the increasing demand for effective treatments, the invention of new drug distribution mechanisms, the escalating usage of budesonide, a rising elderly population susceptible to asthma, and the growth in generic budesonide products. Major trends during the forecast period consist of the incorporation of biologics and biosimilars, progress in drug delivery systems, regulator endorsements for new drug forms, the creation of novel drug delivery systems, and improvements in technology.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21121&type=smp

What External and Internal Drivers Are Contributing to the Growth of the Budesonide Market?

The growth of the budesonide market is anticipated to be driven by the rising prevalence of respiratory illnesses. Such diseases involve the organs and tissues responsible for gas regulation in air-breathing animals. The rise in such cases is predominantly due to escalating air pollution and exposure to particulates and allergens, significantly impacting the frequency of asthma and chronic obstructive lung ailments. Budesonide, typically used in treating respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), lessens inflammation, boosts airflow, and wards off symptoms like shortness of breath and wheezing. For instance, the National Center for Health Statistics (NCHS) reported in May 2024 that the occurrence of current asthma among adults aged 18 and above in the United States showed an increase from 8.4% in 2021 to 8.7% in 2022. In addition, the rate of asthma episodes in the past 12 months in the same demographic ascended from 3.3% in 2021 to 3.7% in 2022. Consequently, the surging prevalence of respiratory diseases is poised to boost the budesonide market expansion.

What Segment Types Define the Budesonide Market Structure?

The budesonide market covered in this report is segmented –

1) By Type: Inhalation Powder, Aerosols, Injectable Suspension, Tablets And Capsules

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Respiratory Disease Treatment, Other Applications

Subsegments:

1) By Inhalation Powder: Dry Powder Inhalers (DPI), Soft Mist Inhalers (SMI)

2) By Aerosols: Metered-Dose Inhalers (MDI), Breath-Activated Inhalers

3) By Injectable Suspension: Pre-filled Syringes, Vials

4) By Tablets And Capsules: Oral Tablets, Oral Capsules

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21121&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Budesonide Market?

North America was the largest region in the budesonide market in 2024. The regions covered in the budesonide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Budesonide Market?

In an effort to improve respiratory treatment methods like oral therapy, boost patient comfort, enhance compliance with treatments, and broaden the range of therapeutic alternatives for managing asthma and other respiratory ailments, primary firms active in the budesonide market are directing their focus towards innovation. Oral budesonide is a form of budesonide ingested orally that is predominantly used for treating inflammation. For instance, Takeda Pharmaceuticals, a pharmaceutical company based in Japan, stated in February 2024 that the Food and Drug Administration (FDA), a federal agency in the US, granted approval to EOHILIA, a budesonide oral suspension. EOHILIA is now the first and only FDA-approved oral medication for patients aged 11 and above with eosinophilic esophagitis (EoE). Furthermore, based on efficacy and safety data from two 12-week multicenter, randomized, double-blind, parallel-group, placebo-controlled studies on subjects aged 11 to 56 having EoE, the FDA also granted its approval to EOHILIA 2 mg administered twice daily.

View the full report here:

https://www.thebusinessresearchcompany.com/report/budesonide-global-market-report

What Is the Definition of the Budesonide Market?

Budesonide is a corticosteroid medication used to reduce inflammation in conditions such as asthma, chronic obstructive pulmonary disease (COPD), inflammatory bowel diseases (Crohn’s disease, ulcerative colitis), and allergic rhinitis. It works by suppressing the immune response and decreasing inflammation in the airways or digestive tract.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21121

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model